Product Image
Please see full prescribing and safety information, including boxed warning, for ENOXAPARIN single-dose syringes.

Available in:

  • 30 mg per 0.3 mL single-dose syringes
  • 40 mg per 0.4 mL single-dose syringes
  • 60 mg per 0.6 mL single-dose syringes
  • 80 mg per 0.8 mL single-dose syringes
  • 100 mg per mL single-dose syringes
  • 120 mg per 0.8 mL single-dose syringes
  • 150 mg per mL single-dose syringes


  • AP Rated
  • Preservative-free
  • DEHP-free
  • PVC-free
  • Not made with natural rubber latex

ENOXAPARIN Sodium Injection, USP*

Brand Name Equivalent: LOVENOX® (LOVENOX is a registered trademark of Sanofi Mature IP)
Therapeutic Category: Anticoagulant

PreventIV Measures® Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the syringe and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
Description Strength Fill
Concentration Container
Closure Unit
of Sale
410-70 Prefilled Syringe 30 mg 0.3 mL 100 mg per mL 0.5 mL N/A 10
410-76 Prefilled Syringe 40 mg 0.4 mL 100 mg per mL 0.5 mL N/A 10
410-77 Graduated Prefilled Syringe 60 mg 0.6 mL 100 mg per mL 1 mL N/A 10
410-78 Graduated Prefilled Syringe 80 mg 0.8 mL 100 mg per mL 1 mL N/A 10
410-71 Graduated Prefilled Syringe 100 mg 1 mL 100 mg per mL 1 mL N/A 10
411-70 Graduated Prefilled Syringe 120 mg 0.8 mL 150 mg per mL 1 mL N/A 10
411-71 Graduated Prefilled Syringe 150 mg 1 mL 150 mg per mL 1 mL N/A 10

WARNING: SPINAL/ EPIDURAL HEMATOMAS Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH) or heparinoids and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
  • Use of indwelling epidural catheters
  • Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, and other anticoagulants
  • A history of traumatic or repeated epidural or spinal punctures
  • A history of spinal deformity or spinal surgery
  • Optimal timing between the administration of enoxaparin sodium injection and neuraxial procedures is not known
Monitor patients frequently for signs and symptoms of neurological impairment. If neurological compromise is noted, urgent treatment is necessary. Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis [see Warnings and Precautions (5.1) and Drug Interactions (7)].